Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy.

Rogério Serafim ParraMarley R FeitosaLetícia C H RibeiroLais A CastroJosé J R RochaOmar Féres

Published in: Gastroenterology research and practice (2018)

Satisfactory trough levels of infliximab were associated with higher rates of clinical remission, mucosal healing, and improved quality of life in inflammatory bowel disease patients on maintenance therapy.

Keyphrases

ulcerative colitis
patients with inflammatory bowel disease
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
systemic lupus erythematosus
patient reported outcomes
cell therapy